Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044

LIFEMD, INC.

(LFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LifeMD to Present at Upcoming June Investor Conferences

05/28/2021 | 04:05pm EDT

NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak Advisors Best Ideas Conference and the 2021 LD Micro Invitational XI. LifeMD will also host 1x1 meetings around the conference presentations. Details for the presentations are as follows:

Capital Peak Advisors Best Ideas Conference
Date: Wednesday, June 2, 2021
Time: 11:00 am ET
Webcast: https://www.webcaster4.com/Webcast/Page/2134/41603  

2021 LD Micro Invitational XI
Hall of Fame LD Micro Presentation
Date: Tuesday, June 8, 2021
Time: 4:30 pm ET
Registration Link: https://ldmicrojune2021.mysequire.com/

About LifeMD
LifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states. LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home.  To learn more, go to LifeMD.com

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects -- both business and financial. While we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

Company Contact                                
LifeMD, Inc.        
Marc Benathen, CFO
Email Contact        

Investor Relations Contacts
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

 


Primary Logo


ę GlobeNewswire 2021
All news about LIFEMD, INC.
10/04LIFEMD : Announces Launch of Public Offering of Common Stock (Form 8-K)
PU
10/04LIFEMD, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights..
AQ
10/04LIFEMD : Announces Closing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulati..
GL
10/04LifeMD Announces Closing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulat..
GL
10/04LifeMD Announces Closing of Public Offering of Common Stock and Exercise of the Underwr..
GL
10/04LIFEMD : Announces Closing of Public Offering of Common Stock and Exercise of the Underwri..
GL
09/30LIFEMD : Announces Pricing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulati..
AQ
09/29AFTER HOURS WATCH LIST SCORECARD : Govx, lcid, lfmd
MT
09/29Health Care Stocks Easing Slightly From Intra-Day Highs Near Close
MT
09/29Health Care Stocks Recovering From Tuesday Selloff
MT
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 95,8 M - -
Net income 2021 -60,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,35x
Yield 2021 -
Capitalization 154 M 154 M -
Capi. / Sales 2021 1,61x
Capi. / Sales 2022 1,07x
Nbr of Employees 56
Free-Float 66,8%
Chart LIFEMD, INC.
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 5,05 $
Average target price 23,00 $
Spread / Average Target 355%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Independent Director & Chief Medical Officer-US
Stefan Galluppi Director & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.-22.66%154
AMAZON.COM, INC.2.41%1 681 570
JD.COM, INC.-4.15%130 769
ETSY, INC.41.97%31 970
WAYFAIR INC.4.13%24 430
ALLEGRO.EU SA-42.54%12 554